Scenario drafting for early technology assessment of next generation sequencing in clinical oncology

BACKGROUND: Next Generation Sequencing (NGS) is expected to lift molecular diagnostics in clinical oncology to the next level. It enables simultaneous identification of mutations in a patient tumor, after which targeted therapy may be assigned. This approach could improve patient survival and/or ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Joosten, S.E.P., Retèl, V.P., Coupé, V.M.H., van den Heuvel, M.M., van Harten, W.H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744630/
https://www.ncbi.nlm.nih.gov/pubmed/26851938
http://dx.doi.org/10.1186/s12885-016-2100-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744630/
https://www.ncbi.nlm.nih.gov/pubmed/26851938
http://dx.doi.org/10.1186/s12885-016-2100-0

Ejemplares similares